Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Validae Health, L.P. — Metsera, Inc. insider: 1 transactions · InsiderLens

Home / Insiders / Validae Health, L.P.

Validae Health, L.P.

10% owner at Metsera, Inc. · on record since Jan 30, 2025

Insider trading activity of Validae Health, L.P.

Transactions on record: 1; since Nov 13, 2025

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Nov 13, 2025

Figures computed from official regulatory filings — methodology.

Companies where Validae Health, L.P. has traded

Metsera, Inc.1 tx · Nov 13, 2025

Track record of Validae Health, L.P.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Validae Health, L.P.

Co-insiders of Validae Health, L.P.

ARCH Venture Fund XIII, L.P.Metsera, Inc.
ARCH Venture Fund XII, L.P.Metsera, Inc.
ARCH Venture Partners XIII, LLCMetsera, Inc.
ARCH Venture Partners XIII, L.P.Metsera, Inc.
ARCH Venture Partners XII, LLCMetsera, Inc.
ARCH Venture Partners XII, L.P.Metsera, Inc.
Bernard Christopher WhittenMetsera, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

BERNS PAUL LMetsera, Inc.

Burow KristinaMetsera, Inc.

CRANDELL KEITHMetsera, Inc.

FMR LLCMetsera, Inc.

GILLIS STEVENMetsera, Inc.

Hubbard BrianMetsera, Inc.

Lang MatthewMetsera, Inc.

Marso StevenMetsera, Inc.

MEANWELL CLIVEMetsera, Inc.

NELSEN ROBERTMetsera, Inc.

Pinto JoshuaMetsera, Inc.

Population Health Partners GP, LLCMetsera, Inc.

Stonehouse Jon PMetsera, Inc.

Visioli ChristopherMetsera, Inc.

Wellington Biomedical Innovation Master Investors (Cayman) II L.P.Metsera, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Metsera, Inc.	Nov 13, 2025	Other	-12,767,462	0.00 USD	$0	SEC